Narmada Agrobase Q2 FY26: Steady Profits Mask Margin Erosion Concerns

Nov 17 2025 10:45 PM IST
share
Share Via
Narmada Agrobase Ltd., a Gujarat-based manufacturer of cotton seed meal cake, cattle feeds, and soya bean meal, reported a net profit of ₹1.03 crores in Q2 FY26, marking a modest 0.98% quarter-on-quarter increase but a concerning 20.16% year-on-year decline. The ₹88.00 crore market capitalisation company, trading at ₹22.33 on the NSE, saw its stock gain 0.81% following the results announcement, though the modest uptick belies deeper operational challenges that warrant investor scrutiny.



Whilst revenue growth of 7.85% QoQ and 16.25% YoY to ₹11.95 crores in Q2 FY26 appears encouraging on the surface, the company's profitability metrics paint a more nuanced picture. Operating margins excluding other income contracted sharply to 10.79% from 20.04% in the year-ago quarter, whilst PAT margins compressed to 8.62% from 12.55%, signalling mounting cost pressures that are eroding the bottom line despite top-line expansion.





Net Profit (Q2 FY26)

₹1.03 Cr

+0.98% QoQ

-20.16% YoY



Revenue (Q2 FY26)

₹11.95 Cr

+16.25% YoY



Operating Margin

10.79%

-922 bps YoY



PAT Margin

8.62%

-393 bps YoY




The company's H1 FY26 performance reveals a similar pattern: whilst net sales reached ₹23.03 crores (up 11.43% YoY), net profit stood at ₹2.05 crores, reflecting a modest 1.49% year-on-year decline. This divergence between revenue growth and profit stagnation underscores the margin compression challenge that has emerged as the defining narrative of Narmada Agrobase's recent financial trajectory.

















































































Quarter Revenue (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin PAT Margin
Sep'25 11.95 +7.85% 1.03 +0.98% 10.79% 8.62%
Jun'25 11.08 -62.18% 1.02 +30.77% 11.82% 9.21%
Mar'25 29.30 +111.71% 0.78 -22.00% 2.01% 2.66%
Dec'24 13.84 +34.63% 1.00 -22.48% 9.68% 7.23%
Sep'24 10.28 -16.15% 1.29 +26.47% 20.04% 12.55%
Jun'24 12.26 -34.61% 1.02 +67.21% 12.89% 8.32%
Mar'24 18.75 0.61 6.13% 3.25%



Financial Performance: Revenue Growth Fails to Translate to Bottom Line



Narmada Agrobase's Q2 FY26 revenue of ₹11.95 crores represents a sequential improvement of 7.85% from Q1 FY26's ₹11.08 crores and a year-on-year expansion of 16.25% from Q2 FY25's ₹10.28 crores. However, this top-line growth has been achieved at the expense of profitability, with operating margins excluding other income plummeting by 922 basis points year-on-year to 10.79%, down from 20.04% in Q2 FY25.



The margin erosion becomes even more pronounced when examining the PAT margin trajectory. In Q2 FY26, PAT margins stood at 8.62%, a sharp contraction from 12.55% in the year-ago quarter and marginally lower than Q1 FY26's 9.21%. This persistent compression suggests structural cost challenges rather than temporary headwinds, with the company struggling to maintain pricing power or control input costs in an increasingly competitive FMCG landscape.





Revenue (Q2 FY26)

₹11.95 Cr

+7.85% QoQ

+16.25% YoY



Net Profit (Q2 FY26)

₹1.03 Cr

+0.98% QoQ

-20.16% YoY



Operating Margin

10.79%

-922 bps YoY



PAT Margin

8.62%

-393 bps YoY




Interest costs have shown volatility, declining to ₹0.20 crores in Q2 FY26 from ₹0.24 crores in both Q1 FY26 and Q2 FY25, providing marginal relief to profitability. However, this modest benefit has been insufficient to offset the broader margin pressures stemming from operational inefficiencies. The tax rate of 25.55% in Q2 FY26 remained relatively stable compared to 27.53% in the year-ago quarter, indicating no significant tax-related headwinds.



On a half-yearly basis (H1 FY26), the company reported net sales of ₹23.03 crores, up 11.43% from H1 FY25's ₹20.66 crores. However, net profit for H1 FY26 stood at ₹2.05 crores, marginally lower than H1 FY25's ₹2.08 crores, reinforcing the narrative of revenue growth failing to translate into proportionate profit expansion. This divergence between top-line and bottom-line performance raises questions about the sustainability of the current business model and the company's ability to defend margins in a challenging operating environment.




Margin Compression Alert


Operating margins have contracted by 922 basis points YoY, falling from 20.04% in Q2 FY25 to 10.79% in Q2 FY26. This sharp decline, coupled with stagnant profit growth despite revenue expansion, signals structural cost pressures that require immediate management attention. Investors should closely monitor whether this trend represents temporary headwinds or a more permanent erosion of competitive positioning.




Operational Challenges: Weak Returns and Below-Average Quality



Narmada Agrobase's operational efficiency metrics paint a concerning picture of capital productivity. The company's average return on capital employed (ROCE) stands at a meagre 7.59%, significantly below industry standards and indicative of suboptimal asset utilisation. The latest ROCE of 10.55%, whilst showing marginal improvement, remains weak and suggests the company generates insufficient returns relative to the capital deployed in the business.



Return on equity (ROE), a critical measure of shareholder value creation, fares even worse at an average of 5.53%, with the latest reading at 6.86%. Higher ROE values indicate superior capital efficiency and profitability, making Narmada Agrobase's single-digit returns a significant red flag for investors seeking companies that can compound shareholder wealth effectively. For context, quality companies typically maintain ROE above 15%, underscoring the substantial gap in Narmada Agrobase's performance.



The company's balance sheet reveals mixed signals. On the positive side, Narmada Agrobase operates with minimal debt, reflected in its average net debt-to-equity ratio of -0.10, effectively making it a net cash company. As of March 2025, long-term debt stood at just ₹1.14 crores against shareholder funds of ₹55.87 crores. This conservative capital structure provides financial flexibility and insulates the company from interest rate volatility.



However, the company's sales-to-capital-employed ratio of 1.47 times suggests relatively inefficient capital deployment, with each rupee of capital generating only ₹1.47 in sales. The EBIT-to-interest coverage ratio of 3.21 times, whilst adequate, remains on the weaker side, indicating limited cushion should operating performance deteriorate further. More concerning is the debt-to-EBITDA ratio of 5.48, which appears elevated and suggests the company would require several years of EBITDA generation to pay down existing debt obligations, despite the overall low absolute debt levels.




Quality Concerns: Below-Average Financial Strength


Narmada Agrobase carries a "Below Average" quality grade, reflecting weak long-term financial performance. With average ROCE of 7.59% and average ROE of 5.53%, the company demonstrates poor capital efficiency and limited ability to generate superior returns for shareholders. Whilst the company benefits from zero promoter pledging and operates with minimal debt, these positives are insufficient to offset the fundamental weakness in profitability metrics. The 5-year sales CAGR of 20.88% and EBIT CAGR of 46.58% provide some optimism, but the sustainability of this growth remains questionable given the recent margin compression trends.




Industry Context: FMCG Sector Headwinds Amplify Company-Specific Challenges



The broader FMCG sector has faced significant headwinds over the past year, with the sector delivering negative returns of -29.37% compared to the Sensex's positive 9.50% gain. Against this challenging backdrop, Narmada Agrobase's 1-year stock return of 39.82% appears impressive, outperforming the sector by a substantial 69.19 percentage points. This outperformance suggests the market had priced in expectations of operational improvement that have yet to fully materialise.



However, the stock's recent performance tells a more sobering story. Over the past month, Narmada Agrobase has declined 8.07% compared to the Sensex's 1.19% gain, resulting in negative alpha of -9.26%. The 3-month performance shows a similar pattern, with the stock down 3.83% versus the Sensex's 5.40% gain, generating alpha of -9.23%. This recent underperformance coincides with the margin compression evident in the quarterly results, suggesting investors are beginning to reassess their optimistic stance.



The company operates in the highly competitive animal feed and agricultural by-products segment, where pricing power is limited and raw material costs are subject to significant volatility. Cotton seed prices, soya bean meal costs, and other input expenses can fluctuate based on agricultural output, weather patterns, and global commodity trends. Narmada Agrobase's inability to pass through these cost increases to customers, as evidenced by the margin compression, suggests limited competitive differentiation and weak bargaining power vis-à-vis both suppliers and customers.




Competitive Positioning: Limited Differentiation in Commoditised Market


Narmada Agrobase operates in a highly commoditised segment of the FMCG industry, where product differentiation is minimal and competition is primarily price-based. The company's ISO 9001:2015 certification provides basic quality assurance but offers limited competitive advantage. With a micro-cap market capitalisation of ₹88.00 crores and minimal institutional ownership at 8.96%, the company lacks the scale and resources to invest in brand building, distribution expansion, or product innovation that could enhance margins. This structural disadvantage becomes particularly acute during periods of raw material inflation, as evidenced by the current margin compression cycle.




Peer Comparison: Valuation Premium Appears Unjustified



When benchmarked against industry peers, Narmada Agrobase's valuation metrics present a mixed picture that warrants careful consideration. The company trades at a price-to-earnings (TTM) ratio of 22.12 times, which appears reasonable in isolation but becomes concerning when viewed alongside its weak profitability metrics and margin compression trajectory.

































































Company P/E (TTM) ROE (%) Debt/Equity P/BV Market Cap (₹ Cr)
Narmada Agrobase 22.12 5.53% -0.10 1.52 88.00
JHS Sven.Lab. NA (Loss Making) 0.49% -0.08 0.59
Norben Tea NA (Loss Making) 1.86% 0.54 4.89
Shri Vasuprada NA (Loss Making) 0.0% 0.46 0.74
Galaxy Cloud 88.73 0.0% -0.67 -4.45
Virat Crane Inds NA (Loss Making) 10.94% 0.10 1.24



Narmada Agrobase's price-to-book value (P/BV) ratio of 1.52 times appears elevated relative to most peers, particularly given its weak ROE of 5.53%. Typically, companies commanding P/BV multiples above 1.5 times demonstrate superior profitability and growth prospects that justify the premium. However, with ROE below 7% and declining margins, the current P/BV multiple suggests the market may be overvaluing the company's asset base relative to its earning power.



The comparison reveals that Narmada Agrobase, despite its profitability challenges, performs better than several loss-making peers. However, when compared to Virat Crane Industries, which boasts an ROE of 10.94% and trades at a P/BV of 1.24 times, Narmada Agrobase's valuation premium appears difficult to justify. The peer comparison underscores that whilst Narmada Agrobase is profitable, its returns on capital are insufficient to support the current valuation, particularly in light of deteriorating margin trends.



Valuation Analysis: Premium Not Supported by Fundamentals



At the current market price of ₹22.33, Narmada Agrobase trades at a P/E (TTM) ratio of 22.12 times, which sits below the industry average P/E of 39 times. On the surface, this suggests the stock trades at a discount to the broader FMCG sector. However, this apparent discount is misleading when one considers the company's weak profitability metrics and deteriorating margin profile.



The company's EV/EBITDA multiple of 17.52 times and EV/EBIT multiple of 18.42 times appear elevated for a business generating average ROCE of 7.59% and facing margin compression. For context, quality companies with sustainable competitive advantages and strong returns on capital typically trade at EV/EBITDA multiples of 15-20 times, but they also demonstrate ROCE in excess of 15-20%, significantly higher than Narmada Agrobase's current levels.





P/E Ratio (TTM)

22.12x



Price to Book Value

1.52x



EV/EBITDA

17.52x



Mojo Score

44/100




The PEG ratio of 0.86, which compares the P/E ratio to earnings growth rate, suggests the stock may be undervalued relative to growth prospects. However, this metric must be interpreted cautiously given the recent margin compression and declining year-on-year profitability. The 5-year earnings growth rate, whilst impressive at 46.58%, may not be sustainable given the current operational challenges and intensifying competitive pressures.



The stock's book value per share stands at ₹14.73, implying the market is willing to pay a 51.52% premium (P/BV of 1.52x) for assets generating an ROE of just 6.86%. This valuation disconnect suggests either the market is anticipating a significant improvement in returns on equity, or the stock is overvalued relative to its fundamental earning power. Given the deteriorating margin trends evident in recent quarters, the latter interpretation appears more plausible.




"At 1.52 times book value and 22 times earnings, Narmada Agrobase commands a valuation premium that its 6.86% ROE and compressing margins simply cannot justify."


Shareholding Pattern: Stable Promoter Base, Minimal Institutional Interest



Narmada Agrobase's shareholding pattern reveals a stable promoter base holding 50.30% of the company as of September 2025, unchanged from the previous quarter. The promoter holding increased from 49.11% in March 2025 to 50.30% in June 2025, reflecting a 119 basis point increase, and has remained stable since. Importantly, there is no promoter pledging, eliminating concerns about financial stress amongst the controlling shareholders.



















































Shareholder Category Sep'25 Jun'25 Mar'25 QoQ Change
Promoter Holding 50.30% 50.30% 49.11% Stable
FII Holding 0.00% 0.00% 0.00%
Mutual Fund Holding 0.00% 0.00% 0.00%
Other DII Holdings 8.96% 8.96% 8.96% Stable
Non-Institutional 40.74% 40.74% 41.93% -119 bps



However, the complete absence of foreign institutional investor (FII) and mutual fund holdings raises significant concerns about institutional confidence in the company's prospects. With total institutional holdings at just 8.96% (entirely from other domestic institutional investors), Narmada Agrobase lacks the credibility stamp that comes with sophisticated investor participation. This absence is particularly telling given the stock's 39.82% gain over the past year, which should have attracted institutional attention if the underlying fundamentals were compelling.



The non-institutional shareholding of 40.74% suggests the stock is primarily held by retail investors and high-net-worth individuals, making it susceptible to higher volatility and liquidity constraints. The minor decline in non-institutional holdings from 41.93% in March 2025 to 40.74% in September 2025 coincides with the period of margin compression, potentially indicating that informed retail investors are reducing exposure as operational challenges become apparent.



Stock Performance: Recent Weakness Reflects Fundamental Deterioration



Narmada Agrobase's stock price performance presents a tale of two distinct periods. Over the longer term, the stock has delivered impressive returns, gaining 39.82% over the past year and 24.06% over six months, significantly outperforming the Sensex's 9.50% and 3.18% gains respectively. This outperformance generated alpha of +30.32% and +20.88%, positioning the stock as a strong performer in the micro-cap space.

























































Period Stock Return Sensex Return Alpha
1 Week -1.59% +1.69% -3.28%
1 Month -8.07% +1.19% -9.26%
3 Months -3.83% +5.40% -9.23%
6 Months +24.06% +3.18% +20.88%
1 Year +39.82% +9.50% +30.32%
2 Years +15.76% +29.12% -13.36%
3 Years -2.91% +37.57% -40.48%



However, the recent performance paints a starkly different picture. Over the past month, the stock has declined 8.07% compared to the Sensex's 1.19% gain, whilst the 3-month performance shows a decline of 3.83% against the Sensex's 5.40% gain. This recent weakness, generating negative alpha of -9.26% and -9.23% respectively, suggests investors are beginning to price in the margin compression and profitability concerns evident in the latest quarterly results.



The stock's high volatility of 50.47% over the past year, compared to the Sensex's 12.26%, underscores the elevated risk profile. With a beta of 1.50, Narmada Agrobase is significantly more volatile than the broader market, amplifying both gains and losses. The risk-adjusted return of 0.79 over the past year, marginally higher than the Sensex's 0.77, suggests the additional volatility has been barely compensated by excess returns.



From a technical perspective, the stock currently exhibits a "Mildly Bullish" trend, having changed from "Sideways" on November 13, 2025 at ₹22.40. However, the stock trades below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating weak momentum. The immediate resistance at ₹23.55 (20-day moving average) and support at ₹14.60 (52-week low) define the near-term trading range, with the stock currently 21.35% below its 52-week high of ₹28.39.



Investment Thesis: Weak Fundamentals Overshadow Valuation Appeal



Narmada Agrobase's investment thesis rests on several conflicting pillars that ultimately tilt towards caution. The company's proprietary Mojo score of 44 out of 100 places it firmly in "SELL" territory, reflecting the consensus view that fundamental weaknesses outweigh any potential valuation appeal. This score has oscillated between "Hold" and "Sell" ratings over recent months, with the current "Sell" recommendation reinstated on November 17, 2025.





Valuation

Very Attractive



Quality Grade

Below Average



Financial Trend

Flat



Technical Trend

Mildly Bullish




Breaking down the Mojo four-dot analysis reveals the core tensions in the investment case. On the positive side, the stock carries a "Very Attractive" valuation grade, suggesting the current price offers value relative to historical levels and peer comparisons. The technical trend is "Mildly Bullish," providing some near-term momentum support. However, these positives are overwhelmed by significant negatives: a "Below Average" quality grade reflecting weak return on capital metrics, and a "Flat" financial trend indicating stagnant operational performance.



The quality assessment is particularly damning. With average ROCE of 7.59% and average ROE of 5.53%, Narmada Agrobase demonstrates poor capital efficiency that limits its ability to create shareholder value over the long term. Higher ROE values indicate superior capital efficiency and profitability, making the company's single-digit returns a critical weakness. Whilst the company benefits from zero promoter pledging and operates with minimal debt, these positives are insufficient to offset the fundamental weakness in profitability metrics.



Key Strengths & Risk Factors





KEY STRENGTHS



  • Stable promoter holding at 50.30% with zero pledging, demonstrating promoter confidence and eliminating financial distress concerns

  • Net cash position with debt-to-equity of -0.10, providing financial flexibility and insulating from interest rate volatility

  • Strong 5-year sales CAGR of 20.88% and EBIT CAGR of 46.58%, indicating historical growth momentum

  • ISO 9001:2015 certification ensuring basic quality standards in manufacturing processes

  • Valuation appears attractive on P/E basis at 22.12x versus industry average of 39x

  • Outperformed FMCG sector by 69.19% over past year, demonstrating relative strength




KEY CONCERNS



  • Operating margins collapsed from 20.04% to 10.79% YoY, representing 922 basis points of erosion

  • Weak ROE of 6.86% and ROCE of 10.55%, significantly below quality company benchmarks of 15%+

  • Net profit declined 20.16% YoY despite 16.25% revenue growth, indicating severe margin pressure

  • Complete absence of FII and mutual fund holdings, signalling lack of institutional confidence

  • High volatility (50.47%) and beta (1.50) expose investors to elevated risk without commensurate returns

  • Limited competitive differentiation in commoditised animal feed market constrains pricing power

  • Below-average quality grade reflecting weak long-term financial performance





Outlook: What Lies Ahead for Narmada Agrobase



The forward outlook for Narmada Agrobase hinges critically on management's ability to arrest the margin compression that has characterised recent quarters. With operating margins declining from 20.04% to 10.79% year-on-year, the company faces an urgent imperative to either improve pricing realisation or reduce input costs. However, given the commoditised nature of the animal feed business and limited product differentiation, achieving sustainable margin improvement will prove challenging.





POSITIVE CATALYSTS



  • Stabilisation of raw material costs could provide margin relief

  • Capacity utilisation improvements driving operating leverage

  • Successful implementation of cost control initiatives

  • Favourable agricultural commodity price trends

  • Expansion into higher-margin product categories




RED FLAGS TO MONITOR



  • Further sequential margin compression in Q3 FY26

  • Inability to restore operating margins above 15%

  • Continued decline in year-on-year profitability

  • Working capital deterioration impacting cash generation

  • Increase in promoter pledging or reduction in promoter holding





Investors should closely monitor several key metrics in upcoming quarters. First, the trajectory of operating margins will be critical – any further sequential decline below 10% would signal deepening structural issues. Second, the company's ability to convert revenue growth into profit growth will determine whether the current margin compression is temporary or permanent. Third, working capital management and cash flow generation will be important, particularly given the company's recent negative operating cash flow of ₹15.00 crores in FY25.



The absence of institutional investor interest remains a significant concern. For Narmada Agrobase to attract sophisticated capital and reduce its reliance on retail investors, it must demonstrate sustained improvement in return on capital metrics and margin stability. Until the company can consistently generate ROE above 12-15% and ROCE above 15%, institutional investors are likely to remain on the sidelines, limiting the stock's upside potential and maintaining elevated volatility.




The Verdict: Margin Erosion Warrants Caution Despite Valuation Appeal


SELL

Score: 44/100


For Fresh Investors: Avoid initiating positions at current levels. Whilst the P/E ratio of 22.12x appears reasonable, the deteriorating margin profile, weak return on capital metrics (ROE 6.86%, ROCE 10.55%), and absence of institutional interest suggest significant fundamental challenges. The 922 basis points of operating margin compression year-on-year indicates structural profitability issues that are unlikely to resolve quickly. Wait for sustained evidence of margin stabilisation and return on capital improvement before considering entry.


For Existing Holders: Consider reducing exposure or exiting positions. The recent quarterly results confirm the margin compression trend is worsening rather than improving, with net profit declining 20.16% YoY despite revenue growth of 16.25%. The stock's recent underperformance (down 8.07% over one month versus Sensex up 1.19%) suggests the market is beginning to price in these fundamental challenges. The lack of institutional ownership and below-average quality grade limit the probability of a sustained recovery.


Fair Value Estimate: ₹16.50 (26.10% downside from current price of ₹22.33). Based on normalised ROE of 6.5% and sustainable P/BV multiple of 1.1x for a below-average quality company, fair value appears significantly below current levels.





Note: ROCE = (EBIT - Other income) / (Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News